Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human (3) Apply Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Maximum residue limits Remove Maximum residue limits filter Referrals Remove Referrals filter

Referral name

Referral status

CMDh final position (2) Apply CMDh final position filter European Commission final decision (1) Apply European Commission final decision filter

Referral safety status

Yes (1) Apply Yes filter

Referral type

Article 31 referrals Remove Article 31 referrals filter Article 36 referrals (prior to July 2012) Remove Article 36 referrals (prior to July 2012) filter Article 107i procedures (1) Apply Article 107i procedures filter

Referral reference number

Referral decision making model

PRAC-CMDh (3) Apply PRAC-CMDh filter

Referral authorisation model

Nationally authorised product(s) (3) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

Revocation Remove Revocation filter Risk minimisation measures (17) Apply Risk minimisation measures filter Suspension (3) Apply Suspension filter Variation (12) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Date of opinion

From:

To:

Decision date

From:

To:

Related medicine

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

3 results

Remove all filtersRemove all filters

Medicine Referrals Remove Referrals filter Maximum residue limits Remove Maximum residue limits filter

Referral type Article 36 referrals (prior to July 2012) Remove Article 36 referrals (prior to July 2012) filter Article 31 referrals Remove Article 31 referrals filter

Referral PRAC recommendation Revocation Remove Revocation filter

Sort by

List item

Referral: Amfepramone-containing medicinal products

amfepramone, associated names: Regenon, Tenuate Retard, Amfepramon-Hormosan, Regenon Retard, Article 31 referrals
Status: European Commission final decision, opinion/position date: 10/11/2022, EC decision date: 13/01/2023, Last updated: 20/01/2023
List item

Referral: Flupirtine-containing medicinal products

flupirtine, Article 31 referrals
Status: CMDh final position, opinion/position date: 21/03/2018, Last updated: 04/05/2018
List item

Referral: Fusafungine containing medicinal products for oromucosal and nasal use

fusafungine, Article 31 referrals
Status: CMDh final position, opinion/position date: 31/03/2016, Last updated: 14/04/2016

3 results

Referral: Amfepramone-containing medicinal products

Referral: Flupirtine-containing medicinal products

Referral: Fusafungine containing medicinal products for oromucosal and nasal use